PRMT5-IN-29 - Moligand™, 10 mM in DMSO , CAS No.2242788-69-6

CAS: 2242788-69-6 Cat. No.: P1497943 Formula: C₁₈H₂₀Cl₃N₅O₅ Molecular Weight: 492.74

GRADE & PURITY Moligand™, 10 mM in DMSO

Storage

Protected from light,Argon charged,Store at -80°C

Shipped In

Dry ice packs + Cold packs

Overview

PRMT5-IN-29 is a potent and orally active PRMT5 Inhibitor with an IC 50 of 1.5 μΜ. PRMT5-IN-29 has the potential for advanced cancers research.

Specifications

Specifications & Purity

Moligand™, 10 mM in DMSO

Storage

Protected from light,Argon charged,Store at -80°C

Shipped In

Dry ice packs + Cold packs

This product requires cold chain shipping. Ground and other economy services are not available.

Grade

Moligand™

Action Type

INHIBITOR

Names and Identifiers

Molecular Weight

492.74

Application Protocols

No tested application protocols are provided in the Product Data for this item.

General guidance for assay setup (not item-specific; verify in your lab):

• Prepare a 10–20 mM DMSO stock; make single-use aliquots and store at −80 °C, protected from light.
• For enzyme assays: Assemble PRMT5–MEP50 with substrate and SAM; pre-incubate with inhibitor; maintain constant DMSO. Include positive (known inhibitor) and negative controls.
• For cellular assays: Seed cells to achieve logarithmic growth at dosing; add inhibitor dilutions to yield uniform DMSO across wells; incubate as required by endpoint; quantify SDMA changes by WB/ELISA or target engagement by CETSA/NanoBRET.
• Data integrity: Use duplicates/triplicates, include vehicle controls, and verify absence of compound fluorescence/absorbance interference in optical readouts.

Refer to internal SOPs and the SDS/CoA for item-specific constraints.

Biological Roles

General background on PRMT5 (literature; not item-specific):

• PRMT5 is a type II protein arginine methyltransferase that catalyzes symmetric dimethylation (SDMA) of arginine residues on histones (e.g., H4R3, H3R8) and numerous non-histone proteins. It functions in a complex with MEP50 (WDR77) and requires S-adenosyl-L-methionine (SAM) as the methyl donor.
• Biological processes influenced by PRMT5 include chromatin remodeling, transcriptional repression/activation context-dependently, RNA splicing (via Sm protein methylation), germ cell development, and ribosome biogenesis.
• Chemical inhibition of PRMT5 is used in research to dissect methylation-dependent signaling, map SDMA proteomes, and study crosstalk with other epigenetic enzymes (e.g., histone acetyltransferases, PRMT1/7).
• Selectivity considerations: PRMT5 shares mechanistic features with other PRMTs; profiling across PRMT isoforms and broader SAM-dependent methyltransferases is essential to attribute phenotypes to on-target PRMT5 modulation.

Note: PRMT5-IN-29 is provided strictly for research use. No medical or clinical claims are made or implied.

Buffer Applications

Not a buffering reagent. No defined pKa/pH buffering range is provided for this item.

Practical assay considerations (general, not item-specific):

• For biochemical PRMT5 assays, typical buffers include HEPES or Tris (pH 7.5–8.0) with salt (e.g., 150 mM NaCl), Mg2+ if required by auxiliary enzymes in coupled assays, and reducing agent (1–5 mM DTT or TCEP). Include BSA or low nonionic detergent to reduce nonspecific binding where appropriate.
• Maintain consistent DMSO percentage across wells; pre-dilute inhibitor stocks to limit solvent shocks.
• For cellular assays, use standard culture media with matched vehicle controls; avoid precipitation by pre-mixing inhibitor into media with gentle agitation before cell addition.

Green Alternatives

While PRMT5-IN-29 is a specialized research chemical, greener handling can reduce environmental impact.

Opportunities (general guidance):

• Solvent selection: Prefer lower-toxicity solvents for routine cleaning and dilution (ethanol, isopropanol, water with minimal DMSO) where compatible with solubility and assay needs. Reserve DMF/MeCN for necessary steps.
• Minimize DMSO load: Prepare higher-concentration stocks to keep final assay DMSO ≤0.1–0.2% v/v when biology permits, reducing solvent waste.
• Micro-scale formats: Use 384/1536-well miniaturization to reduce chemical and solvent consumption in screening.
• Reusability: Prepare a single master stock and distribute to aliquots to prevent degradation and repeat syntheses.

Trade-offs:

• Greener solvents may not solubilize lipophilic scaffolds; co-solvent systems can mitigate but require revalidation of biological compatibility.

Compact comparison (general):

• DMSO: Excellent solvency; moderate EHS profile; widely accepted in bioassays.
• Ethanol/i-PrOH: Greener, but limited solvency for very hydrophobic chemotypes.
• MeCN/DMF: Effective but less green; use sparingly and ensure proper waste segregation.

Implement appropriate waste management for organic solvents and follow institutional green-chemistry policies.

Pharmaceutical Uses

This product is supplied for research use only. It is not an active pharmaceutical ingredient, excipient, or drug and is not intended for human or veterinary use.

Research and development context (general):

• Small-molecule PRMT5 inhibitors such as PRMT5-IN-29 may be used as reference compounds in discovery workflows, including SAR benchmarking, target validation, and method development (e.g., LC–MS/MS bioanalytical assays).
• Any formulation-related work should be confined to preclinical research settings (e.g., optimizing solubilization vehicles for in vitro dosing). No pharmacopeial status or compendial monograph is indicated for this item.

Physical Properties

Item-specific properties:

• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• Melting point: Not specified for this item; refer to CoA/Spec Sheet.
• Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
• Density: Not specified for this item; refer to CoA/Spec Sheet.
• Solubility: Not specified for this item; refer to CoA/Spec Sheet.
• LogP, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature, not item-specific):

• Small-molecule epigenetic inhibitors are commonly supplied as solids and prepared as concentrated DMSO stocks (e.g., 10–50 mM) for biochemical or cell-based assays. Actual solubility limits, hygroscopicity, and polymorphism may vary by scaffold; always verify against the lot-specific CoA and perform a small-scale solubility test in your intended assay matrix.

Quality & Grades

Item-specific grade: Moligand™ (from Product Data).

What this implies (general description; not a specification):

• Moligand™ items are intended for research screening and ligand discovery workflows, emphasizing well-defined identity and suitability for biochemical and cellular assays. They are not pharmaceuticals and are supplied for research use only.
• Identity is typically supported by analytical characterization (e.g., NMR, MS, HPLC/UPLC). Exact acceptance criteria and purity thresholds are not specified here; refer to the item’s CoA/Spec Sheet for lot-specific data.

Best practices for QC on receipt:

• Verify identity via LC–MS against the reference mass and retention time when available.
• Confirm purity by your in-house method suited to the scaffold (reverse-phase HPLC/UPLC with DAD/MS). If UV cutoff or epsilon values are needed for quantitation, consult the CoA or determine experimentally.
• For bioassay reproducibility, record the lot number and prepare a master DMSO stock to minimize freeze–thaw cycling.

Reaction & Applications

Item-specific synthetic reactivity is not applicable—this product is intended as a small-molecule tool compound for PRMT5-related research rather than as a building block.

Research applications (general, literature-based; not item-specific claims):

• Chemical biology: Use as a reference inhibitor in assays interrogating PRMT5 catalytic activity (arginine symmetric dimethylation) on peptide or protein substrates.
• Epigenetics workflows: Evaluate modulation of methylation marks on histones and non-histone proteins via western blotting with SDMA-specific antibodies or mass spectrometry-based methyl-arginine profiling.
• Cellular assays: Measure target engagement by CETSA/ITDR, NanoBRET/bioluminescence resonance energy transfer, or reporter assays; monitor functional readouts tied to PRMT5-mediated transcriptional regulation.
• Proteomics: Apply competitive chemoproteomics to assess selectivity against other PRMT isoforms (PRMT1, PRMT7) and methyltransferases.

Practical notes:

• Prepare concentrated DMSO stocks and avoid repeated freeze–thaw; dilute into assay buffers to final DMSO of ≤0.1–0.5% where possible.
• Include orthogonal controls: inactive analogs, unrelated inhibitors, and vehicle controls to deconvolute off-target and DMSO effects.
• Assess time-dependence and reversibility in kinetic assays; PRMT5 inhibitors may exhibit slow-binding behavior depending on scaffold.

Reaction Conditions

No chemical reaction conditions are specified for this item. The following are general assay handling conditions for small-molecule PRMT5 inhibitors (literature-based; not item-specific):

• Stock solutions: Prepare in dry DMSO at 10–50 mM. Pass through a 0.2 µm PTFE filter if particulate is observed. Store as single-use aliquots at −80 °C, protected from light.
• Biochemical assays: Typical enzyme assays run at pH 7.5–8.0, 25–30 °C, with PRMT5–MEP50 complex, peptide/protein substrate, and SAM. Pre-incubate inhibitor with enzyme (e.g., 10–30 min) to assess slow-binding effects. Readouts may include radiometric methyl transfer, coupled SAH detection, or MS.
• Cellular assays: Dose–response titrations across 8–12 points (e.g., 0.1 nM–30 µM) with a constant final DMSO fraction (≤0.1–0.5%). Incubation times vary from 2–24 h depending on endpoint (SDMA levels by western blot, reporter activity, or CETSA shift).
• Stability checks: Monitor for precipitation upon dilution into aqueous buffers. Use fresh dilutions and avoid repeated freeze–thaw cycles to prevent potency drift.

Consult the item’s CoA and SDS before establishing definitive conditions.

Safety & Handling

Item-specific safety data:

• Signal word, H-statements, GHS classification, pictograms: Not specified for this item; refer to SDS.
• Storage conditions (from Product Data): Protect from light; maintain under argon; store at −80 °C.
• Shipping: Dry ice packs + cold packs (from Product Data).

General safety guidance (not item-specific; consult SDS for authoritative data):

• Handle in a fume hood with standard lab PPE: lab coat, nitrile gloves, and safety glasses. Avoid inhalation of dust/aerosols and skin/eye contact.
• PRMT5 inhibitors are research chemicals; toxicity profiles may be incomplete. Treat as harmful if swallowed, inhaled, or in contact with skin/eyes until SDS confirms otherwise.
• Incompatibilities typically include strong oxidizers and conditions that promote hydrolysis or photodegradation; keep tightly sealed under inert gas as directed.
• First aid (overview): rinse eyes/skin with water for 15 minutes upon contact; move to fresh air after inhalation; seek medical attention if symptoms persist. Spill response: avoid dust generation, absorb with inert material, and dispose according to institutional and local regulations.
• Waste: Collect as halogen-free organic waste unless SDS dictates otherwise. Decontaminate surfaces with appropriate solvent/soap solution.

Solvent Selection

Item-specific solubility: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for small-molecule PRMT5 inhibitors (literature-based, not item-specific):

• Primary stock solvent: DMSO is typically preferred due to broad solubilizing power and assay compatibility up to 0.1–1% v/v in many biochemical/cell assays.
• Alternative solvents for intermediate processing: DMF, acetonitrile, ethanol, or isopropanol may assist in co-solvent systems. Aqueous buffers often require co-solvent plus surfactant (e.g., 0.01–0.05% polysorbate) to prevent precipitation; validate for your biology.
• Avoid basic aqueous media when scaffolds contain hydrolysis-prone linkages (amide/ester/urea) unless stability is verified.
• Degassed, anhydrous solvents can improve stability for moisture- or oxygen-sensitive scaffolds; this product is supplied argon-charged and light-protected—maintain these conditions when feasible.

Quick comparison (general):

• DMSO: Highest solubility range; can affect cells at >0.5–1% v/v.
• DMF: Similar solvation; higher toxicity; limit in bioassays.
• MeCN: Useful in LC and for HPLC calibration, lower solvation of very lipophilic chemotypes.
• EtOH/i-PrOH: Good miscibility with aqueous buffers; solvation limited for very lipophilic compounds. Always perform a small-scale solubility/stability check in your target matrix.

Storage & Reconstitution

Item-specific storage and shipping (from Product Data):

• Store at −80 °C.
• Protect from light.
• Maintain under argon (argon-charged container).
• Shipped on dry ice packs + cold packs.

Reconstitution and handling (general guidance; not item-specific):

• Allow container to equilibrate to room temperature in a desiccator before opening to prevent moisture condensation.
• Prepare concentrated stocks in anhydrous DMSO. If aqueous working solutions are required, dilute immediately before use into buffer while mixing to avoid precipitation. Keep final DMSO within tolerances of your assay.
• Aliquot stocks into single-use vials to avoid freeze–thaw cycles. Store aliquots at −80 °C, protected from light and under inert atmosphere when feasible.
• Inspect solutions for haze/precipitate/color change; discard if instability is observed.

Note: Appearance, exact solubility, and stability windows are not specified for this item; refer to the CoA/Spec Sheet and SDS for definitive, lot-specific instructions.

Structure & Identity

Item-specific identifiers available: SKU P1497943; Product name PRMT5-IN-29; CAS 2242788-69-6.

• Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
• Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
• SMILES: Not specified for this item; refer to CoA/Spec Sheet.
• InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
• CID (PubChem): Not specified for this item; refer to CoA/Spec Sheet.

General information (literature):

• PRMT5-IN-29 denotes a small-molecule inhibitor designed to modulate PRMT5 (protein arginine methyltransferase 5) activity for chemical biology and screening applications. Without a provided structure, ring systems, heteroatoms, and stereochemistry cannot be described for this specific lot. If structural details are required, consult the CoA/SDS or manufacturer dataset for 2D/3D depictions and identifiers.

Synthetic Utility

As a finished tool compound rather than a building block, this item is not typically used as a substrate or reagent in synthetic transformations.

General considerations (literature-based; not item-specific):

• If derivatization is desired for probe development (e.g., photoaffinity or biotinylated tags), common strategies include appending linkers via peripheral amide/urea/ether positions when permitted by structure–activity relationships (SAR). Activity-guided design is required to retain PRMT5 engagement.
• For analytical method development, stable-isotope-labeled analogs are often prepared to serve as internal standards for LC–MS quantitation in biochemical matrices.
• Protect the integrity of the pharmacophore during conjugation; even minor modifications can substantially reduce PRMT5 affinity/selectivity. Parallel synthesis and rapid biochemical screening are recommended to validate any synthetic modifications.

Target Specificity

Item-specific target, isoform selectivity, and binding mode are not provided in the Product Data.

General note (not item-specific):

• PRMT5-IN-29 denotes a PRMT5-focused inhibitor name; however, quantitative selectivity versus other PRMTs (e.g., PRMT1/7) and methyltransferases must be established experimentally for each scaffold and lot. Techniques include enzyme panels, chemoproteomics, CETSA/NanoBRET, and cellular SDMA readouts.
• Refer to the CoA/Spec Sheet or associated technical notes for any available target engagement or selectivity data specific to this item.

Frequently Asked Questions

What is Moligand??

Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.

How should this product be stored?

Store at ?80 °C, protected from light, under argon. It is supplied under an argon blanket; reseal under inert gas after each use.

How is this product shipped?

This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.

What are the CAS number, molecular formula and molecular weight?

The CAS Number is 2242788-69-6, the molecular formula is C18H20Cl3N5O5, and the molecular weight is 492.74 g/mol.

What documentation is provided?

Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.